Dr. Huma Qamar Emerges as a Pivotal Leader in Rare Disease Research and Public Health Strategy

Dr. Huma Qamar, MD, MPH, CMI, continues to gain national recognition for her work at the intersection of clinical innovation, public health, and inclusive leadership. Currently serving as Chief Medical Officer at Ocugen, Inc. (NASDAQ: OCGN), Dr. Qamar is leading efforts to bring forward groundbreaking treatments for rare retinal diseases, while also championing a broader […]